ARGENX, a global biopharmaceutical company headquartered in Amsterdam, the Netherlands, will acquire FORTE BIOSCIENCES in cash of $77 per share.

Zhitongcaijing · 2d ago
ARGENX, a global biopharmaceutical company headquartered in Amsterdam, the Netherlands, will acquire FORTE BIOSCIENCES in cash of $77 per share.